Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-05-23
2006-05-23
Minnifield, N. M. (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023700, C536S024320, C435S006120, C435S069100, C435S069300, C435S252300, C435S254110, C435S320100, C514S04400A, C424S244100
Reexamination Certificate
active
07049419
ABSTRACT:
Disclosed and claimed are: epitopic regions of Pneumococcal Surface Protein C or “PspC”, different clades of PspC, isolated and/or purified nucleic acid molecules such as DNA encoding a fragment or portion of PspC such as an epitopic region of PspC or at least one epitope of PspC, uses for such nucleic acid molecules, e.g., to detect the presence of PspC or ofS. pneumoniaeby detecting a nucleic acid molecule therefor in a sample such as by amplification and/or a polymerase chain reaction, vectors or plasmids which contain and/or express such nucleic acid molecles, e.g., in vitro or in vivo, immunological, immunogenic or vaccine compositions including at least one PspC and/or a portion thereof (such as at least one epitopic region of at least one PspC and/or at least one polypeptide encoding at least one epitope of at least one PspC), either alone or in further combination with at least one second pneumococcal antigen, such as at least one different PspC and/or a fragment thereof and/or at least one PspA and/or at least one epitopic region of at least one PspA and/or at least one polypeptide including at least one epitope of PspA. PspC or a fragment thereof, and thus a composition including PspC or a fragment thereof, can be administered by the same routes, and in approximately the same amounts, as PspA. Thus, the invention further provides methods for administering PspC or a fragment thereof, as well as uses of PspC or a fragment thereof to formulate such compositions.
REFERENCES:
patent: 5476929 (1995-12-01), Briles et al.
patent: 5679768 (1997-10-01), Briles et al.
patent: 5728387 (1998-03-01), Briles et al.
patent: 5753463 (1998-05-01), Briles et al.
patent: 5804193 (1998-09-01), Briles et al.
patent: 5856170 (1999-01-01), Briles et al.
patent: 5871943 (1999-02-01), Briles et al.
patent: 5955089 (1999-09-01), Briles et al.
patent: 5965141 (1999-10-01), Briles et al.
patent: 5980909 (1999-11-01), Briles et al.
patent: 6004802 (1999-12-01), Briles et al.
patent: 6027734 (2000-02-01), Briles et al.
patent: 6042838 (2000-03-01), Briles et al.
patent: 6231870 (2001-05-01), Briles et al.
patent: 6232116 (2001-05-01), Briles et al.
patent: 6245335 (2001-06-01), Masure et al.
patent: 6291654 (2001-09-01), Hostetter et al.
patent: 6420135 (2002-07-01), Kunsch et al.
patent: 6500613 (2002-12-01), Briles et al.
patent: 6503511 (2003-01-01), Wizemann et al.
patent: 6573082 (2003-06-01), Choi et al.
patent: 6638516 (2003-10-01), Becker et al.
patent: 6784164 (2004-08-01), Masure et al.
patent: 6943241 (2005-09-01), Isogai et al.
patent: 2001/0016200 (2001-08-01), Briles et al.
patent: 2002/0061545 (2002-05-01), Choi et al.
patent: 2003/0059438 (2003-03-01), Briles et al.
patent: 2003/0091577 (2003-05-01), Gilbert et al.
patent: 2003/0096950 (2003-05-01), Tuomanen et al.
patent: 2004/0067237 (2004-04-01), Becker et al.
patent: 2004/0077847 (2004-04-01), Briles et al.
patent: 2004/0081662 (2004-04-01), Hermand et al.
patent: 2004/0241638 (2004-12-01), Thonnard
patent: 2004/0241687 (2004-12-01), Thonnard et al.
patent: 2005/0031646 (2005-02-01), Capiau et al.
patent: 2005/0118659 (2005-06-01), Castado et al.
patent: 2005/0196405 (2005-09-01), Briles et al.
patent: 2104014 (1992-08-01), None
patent: 2116261 (1994-10-01), None
patent: 2149345 (1995-11-01), None
patent: 2232033 (1997-03-01), None
patent: 2253252 (1997-11-01), None
patent: 0622081 (1994-11-01), None
patent: 0 695 803 (1996-02-01), None
patent: 2477185 (2004-11-01), None
patent: WO 92/14488 (1992-09-01), None
patent: WO 93/24000 (1993-12-01), None
patent: WO 97/09994 (1997-03-01), None
patent: WO 98/21337 (1998-05-01), None
patent: WO 99/53940 (1999-10-01), None
patent: WO 00/56359 (2000-09-01), None
patent: WO 00/76541 (2000-12-01), None
patent: WO 02/08426 (2002-01-01), None
Jarva et al, Molecular Immunology, 2003, 40:95-107.
Briles et al, International Congress Series, 2003, 1257:27-31.
Briles, “PspA's Affect on Lactoferrin Killing ofPneumococci,” National Institute of Health/National Institute of Allergy and Infectious Diseases Grant No. 1 RO1 AI0610 38-01, pp. 2 (2003).
Baltimore et al.,“Pneumoccal Infections,” inBacterial Infection,Chapter 28, Brachman (ed.), Plenum Publishing Corporation, New York (1997).
Beall et al., “Pneumococcal pspA SequenceTypes of Prevalent MultiresistantPneumococcalStrains in the United States of Internationally Disseminated Clones”,J. Clin. Microbiol,38(101):3663-3669 (2000).
Kuroki et al., “Pulmonary Surfactant Apoprotein A Structure and Modulation of Surfactant Secretion by Rat Aveolar Type II Cells”,J. Biol. Chem.,263(7):3388-3394 (1988).
Kolberg et al., “Streptococcus pneumoniaeHeat Shock Protein 70 does not Induce Human Antibody Responses During Infection”,FEMS Immunol,&Med. Microb.,29:289-294 (2000).
McDaniel et al., “Localization of Protection-Eliciting Epitopes on PsPA ofStrepiococcus pneumoniaeBetween Amino Acid Residues 192 and 260”,Microbial Pathogenesis,17:323-337 (1994).
Briles et al., “The Potential to Use PspA and OtherPneumococcalProteins to Elicit Protection AgainstPneumococcalInfection”,Vaccine,18:1707-1711 (2000).
Nabors et al., “Immunization of Healthy Adults with a Single Recombinant Pneumococcal Surface Protein A (PsPA) Variant Stimulates Broadly Cross-reactive Antibodies to Heterlogous PspA Molecules”,Vaccine,18:1743-1754 (2000).
Brooks-Walter et al., “The pspC Gene ofStreptococcus pneumoniaeEncodes a Polymorphic Protein, PspC, Which Elicits Cross-Reactive Antibodies to PspA and Provides Immunity toPneumococcalBacteremia”,Infection&Immunity,67(12):6533-6542 (1999).
Hollingshead et al., “Diversity of PspA: Mosaic Genes and Evidence for Past Recombination inStreptococcus pneumoniae”, Infection&Immunity,68(10):5889-5900 (2000).
Håkansson et al., “Characterization of Binding of Human Lactoferrin toPneumococcalSurface Protein A”,Infection&Immunity69(5):3372-3381 (2001).
Dave et al., “PspC, aPneumococcalSurface Protein, Binds Human Factor H”,Infection&Immunity,69(5):3435-3437 (2001).
Brooks-Walter, ASM Annual Mtg. 1997 p. 35 Abstract #B-37 (1997) (Abstract Only).
Hammerschmidt et al., “SpsA, A NovelPneumococcalSurface Protein With Specific Binding to Secretory Immunoglobin A and Secretory Component, Molecular Immunology,” 25:1113-1124 (1997).
Tomasz, “Choline in the Cell Wall of a Bacterium: Novel Type of Polymer-Linked Choline inPneumococcus ,” Science,157:694-697 (1967).
Briese et al., “Interactions of thePneumacoccalAmidase with Lipoteichoic Acid and Choline,”Eur. J. Biochem.,146:417-427 (1985).
Sanchez-Beato et al., “Molecular Characterization of a Family of Choline-Binding Proteins ofClostridium beijerinckilNCIB 8052. Evolution and Gene Redundancy in Prokaryotic Cell,”Gene,180:13-21 (1996).
Sanchez-Beato et al., Molecular Characterization of PcpA: A Novel Choline-Binding Protein ofStreptococcus pneumoniae, FEMS Microbiology Letters,164:207-214 (1997).
Banas et al., “Sequence Analysis of the Gene for the Glucan-Binding Protein ofStreptococcus mutansIngritt,”Infection and Immunity,58(3):667-673 (1990).
Briles et al., “PspA and PspC: Their Potential for Use asPneumococcalVaccines,”Microbial Drug Resistance,3(4):401-408 (1997).
Briles et al., “PspA, a Protection-ElicitingPneumococcalProtein: Immunogenicity of Isolated Native PspA in Mice,”Vaccine14(9):858-867 (1996).
McDaniel et al., “Use of Insertional Inactivation to Facilitate Studies of Biological Properties ofPneumococcalSurface Protein A (PspA),”J. Exp. Med.,165:381-394 (1987).
McDaniel et al., “PspA, A Surface Protein ofStreptococcus pneumoniae, Is Capable of Eliciting Protection AgainstPneumococciof More Than One Capsular Type,”Infection and Immunity,222-228 (1991).
McDaniel et al., “Molecular Localization of Variable and Conserved Regions of pspA and Identification of Additional
Briles David E.
Brooks-Walter Alexis
Hollingshead Susan K.
Minnifield N. M.
Nixon & Peabody LLP
The UAB Research Foundation
LandOfFree
Pneumococcal surface protein C (PspC), epitopic regions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pneumococcal surface protein C (PspC), epitopic regions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pneumococcal surface protein C (PspC), epitopic regions and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3533415